A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus bisphosphonate in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT)
Not Applicable
Completed
- Conditions
- Post-menopausal osteoporosisMusculoskeletal DiseasesOsteoporosis
- Registration Number
- ISRCTN10335153
- Lead Sponsor
- Institut de Recherches Internationales Servier (France)
- Brief Summary
2010 results in https://www.ncbi.nlm.nih.gov/pubmed/20512336/
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
1. Women of at least 50 years old
2. Post-menopausal for at least 5 years
3. Osteoporosis
Exclusion Criteria
1. Evolutive cancer during the past 5 years with a risk of bone metastases
2. Body Mass Index less than 18 or greater than 30 kg/m^2
3. Severe malabsorption
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method